Plasma microRNA vary in association with the progression of Alzheimer's disease

INTRODUCTION: Early intervention in Alzheimer's disease (AD) requires the development of an easily administered test that is able to identify those at risk. Focusing on microRNA robustly detected in plasma and standardizing the analysis strategy, we sought to identify disease‐stage specific bio...

Descripción completa

Detalles Bibliográficos
Autores principales: Guévremont, Diane, Tsui, Helen, Knight, Robert, Fowler, Chris J., Masters, Colin L., Martins, Ralph N., Abraham, Wickliffe C., Tate, Warren P., Cutfield, Nicholas J., Williams, Joanna M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Blood–Based Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817674/
https://www.ncbi.nlm.nih.gov/pubmed/35141392
http://dx.doi.org/10.1002/dad2.12251

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817674/
https://www.ncbi.nlm.nih.gov/pubmed/35141392
http://dx.doi.org/10.1002/dad2.12251

Ejemplares similares